Table 5.

Number (%) of patients who reported each of the adverse events that occurred in >5% of study patients*

Adverse eventPlacebo, n = 36Botulinum toxin type B
5,000 U, n = 3610,000 U, n = 37
* Sorted by incidence within the 10,000-U group.
CD = cervical dystonia.
Neck pain secondary to CD9 (25)11 (31)10 (27)
Dry mouth1 (3)5 (14)9 (24)
Pain5 (14)2 (6)9 (24)
Dysphagia1 (3)4 (11)8 (22)
Headache3 (8)9 (25)5 (14)
Worsening torticollis2 (6)3 (8)5 (14)
Accidental injury1 (3)3 (8)4 (11)
Injection site pain3 (8)2 (6)4 (11)
Dyspepsia3 (8)1 (3)4 (11)
Infection10 (28)9 (25)3 (8)
Flu syndrome1 (3)3 (8)3 (8)
Taste perversion0 (0)0 (0)3 (8)